New 2-Dose vaccine aims to protect infants from deadly diarrhea
NCT ID NCT06663436
First seen Jan 08, 2026 · Last updated Apr 30, 2026 · Updated 19 times
Summary
This study tested a new vaccine called altSonflex1-2-3 to see if it can protect African infants from shigellosis, a severe type of diarrhea. About 200 healthy infants received either the vaccine or a control, and researchers measured their immune response and any side effects. The goal was to find out if a 2-dose schedule works well and is safe for this age group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIARRHOEA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Kericho, 20200, Kenya
Conditions
Explore the condition pages connected to this study.